Details for 2018771465

Up to date per 03.04.2026

Actions

Title / Product Name

BEHANDLUNG VON KREBS MIT EINEM SEMAPHORIN-4D-ANTIKÖRPER IN KOMBINATION MIT EINEM EPIGENETISCHEN MODULIERUNGSMITTEL

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018771465

EP Publication Number

3600419

E-Number

1596735

Language

PCT Number

US18022414

Publication Date

05.02.2020 A

09.08.2023 B1

Registration Date

09.08.2023

AT Publication Date

15.08.2023

Application Date

14.03.2018

Registration Number

Priorities

20.03.2017

201762473731 P

IPC

A61K 39/395 20060101AFI20201028BHEP

Maximum Duration of Protection

14.03.2038

Owner

Vaccinex, Inc.1895 Mt. Hope Avenue Rochester, NY 14620US

Representative

Dipl.-Ing. Dr. techn. Elisabeth SchoberBrigittenauer Lände 50/11200 WienAT

Inventor

EVANS, Elizabeth41 Main Street Bloomfield, New York 14469US

SMITH, Ernest S.67 Longton Place West Henrietta, New York 14586US

ZAUDERER, Maurice44 Woodland Road Pittsford, New York 14534US

Information about Fees